Market Overview:
The global genetic analyzer market is expected to grow at a CAGR of 10.8% from 2018 to 2030. The market growth is attributed to the increasing demand for genetic analyzers in the diagnostics centres, drug discovery, research and development, and other applications. The DNA microarrays segment is expected to dominate the global genetic analyzer market during the forecast period owing to its high adoption rate in various applications. However, the next generation sequencing segment is projected to grow at a higher CAGR during the forecast period due to its growing demand for precision medicine and personalized healthcare.
Product Definition:
A genetic analyzer is a laboratory instrument used to determine the sequence of nucleotides in DNA or RNA. The importance of genetic analyzers is that they allow scientists to study the genes of organisms and how they are expressed.
DNA Microarrays:
DNA microarrays are a new technology that has evolved from the development of genetic microarrays. The latter is used for gene expression analysis by hybridization. DNA microarrays have been designed to analyze multiple genes at once, which makes them an ideal tool for analyzing complex diseases and traits in biological samples such as blood, urine, hair, skin cells or swabs.
PCR:
Polymerase Chain Reaction (PCR) is a technique used in genetic analyzers that allows for the amplification of specific DNA sequences from a DNA sample. The technique was developed by the F. Hoffmann-La Roche Ltd., which patented it in 1988, and has since been widely used as an analytical tool in molecular biology. PCR is commonly used to detect and measure genotypes at higher rates than conventional techniques such as Southern Blotting or Northern Blotting.
Application Insights:
The diagnostics centers segment dominated the global genetic analyzer market in terms of revenue in 2017. This is attributed to factors such as rising prevalence of diseases and increasing investments by governments for the development of diagnostic centers. For instance, according to WHO, around 30 million people are diagnosed with cancer every year and it is estimated that this number will reach 70 million by 2030. Therefore, an increase in the incidence rate of various diseases leads to an increased demand for diagnosis which subsequently boosts market growth.
Moreover, within diagnostics centers another lucrative segment includes drug discovery & development which accounts for a significant share owing to initiatives taken up by companies such as Merck Millipore and Thermo Fisher Scientific towards personalized medicine through pharmacogenomics and pharmacogenetics respectively. These factors are anticipated to drive this application segment over the forecast period thereby contributing toward overall growth during the study period from 2018-2030 ¢â‚¬Å“ See more at: //www.
Regional Analysis:
North America dominated the global market in 2017. This can be attributed to the presence of a large number of players, increased funding for genomic research and rising awareness about genetic tests. Moreover, growing penetration rates for advanced diagnostic technologies such as NGS are expected to drive regional growth over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to increasing government initiatives and investments in genomics & personalized medicine across emerging economies such as China & India. In addition, rapidly improving healthcare infrastructure coupled with growing R&D activities by major pharmaceutical companies is also likely boost regional demand during the forecast period (2018-2030).
Moreover, an increase in disease prevalence has led researchers from around the world to study these diseases at a deeper level which will further propel market development over next eight years (from 2018 To 2030).
Growth Factors:
- Increasing demand for personalized medicine
- Growing application of genetic analyzers in research laboratories
- Rising number of genetic disorders and their diagnosis
- Technological advancements in the field of genetic analyzers
- Increasing funding for research on genetics and genomics
Scope Of The Report
Report Attributes
Report Details
Report Title
Genetic Analyzer Market Research Report
By Type
DNA Microarrays, PCR, Next Generation Sequencing, Serial Analysis of Gene Expression, Northern Blotting
By Application
Diagnostics Centres, Drug Discovery, Research and Development, Others
By Companies
Thermo Fisher Scientific, BioRad Laboratories, Abbott laboratories, AutoGenomics, Celera Group, PerkinElmer, Quest Diagnostics, ELITech Group, Applied Biosystems, Transgenomic
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
150
Number of Tables & Figures
105
Customization Available
Yes, the report can be customized as per your need.
Global Genetic Analyzer Market Report Segments:
The global Genetic Analyzer market is segmented on the basis of:
Types
DNA Microarrays, PCR, Next Generation Sequencing, Serial Analysis of Gene Expression, Northern Blotting
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Diagnostics Centres, Drug Discovery, Research and Development, Others
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Thermo Fisher Scientific
- BioRad Laboratories
- Abbott laboratories
- AutoGenomics
- Celera Group
- PerkinElmer
- Quest Diagnostics
- ELITech Group
- Applied Biosystems
- Transgenomic
Highlights of The Genetic Analyzer Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- DNA Microarrays
- PCR
- Next Generation Sequencing
- Serial Analysis of Gene Expression
- Northern Blotting
- By Application:
- Diagnostics Centres
- Drug Discovery
- Research and Development
- Others
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Genetic Analyzer Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
A genetic analyzer is a laboratory instrument that can be used to identify the sequence of DNA (deoxyribonucleic acid) in a sample. This information can then be used to determine the identity of the sample's source and, in some cases, its ancestry.
Some of the major companies in the genetic analyzer market are Thermo Fisher Scientific, BioRad Laboratories, Abbott laboratories, AutoGenomics, Celera Group, PerkinElmer, Quest Diagnostics, ELITech Group, Applied Biosystems, Transgenomic.
The genetic analyzer market is expected to register a CAGR of 10.8%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Genetic Analyzer Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Genetic Analyzer Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Genetic Analyzer Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Genetic Analyzer Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Genetic Analyzer Market Size & Forecast, 2020-2028
4.5.1 Genetic Analyzer Market Size and Y-o-Y Growth
4.5.2 Genetic Analyzer Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 DNA Microarrays
5.2.2 PCR
5.2.3 Next Generation Sequencing
5.2.4 Serial Analysis of Gene Expression
5.2.5 Northern Blotting
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Diagnostics Centres
6.2.2 Drug Discovery
6.2.3 Research and Development
6.2.4 Others
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Genetic Analyzer Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Genetic Analyzer Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 DNA Microarrays
9.6.2 PCR
9.6.3 Next Generation Sequencing
9.6.4 Serial Analysis of Gene Expression
9.6.5 Northern Blotting
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Diagnostics Centres
9.10.2 Drug Discovery
9.10.3 Research and Development
9.10.4 Others
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 DNA Microarrays
10.6.2 PCR
10.6.3 Next Generation Sequencing
10.6.4 Serial Analysis of Gene Expression
10.6.5 Northern Blotting
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Diagnostics Centres
10.10.2 Drug Discovery
10.10.3 Research and Development
10.10.4 Others
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 DNA Microarrays
11.6.2 PCR
11.6.3 Next Generation Sequencing
11.6.4 Serial Analysis of Gene Expression
11.6.5 Northern Blotting
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Diagnostics Centres
11.10.2 Drug Discovery
11.10.3 Research and Development
11.10.4 Others
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 DNA Microarrays
12.6.2 PCR
12.6.3 Next Generation Sequencing
12.6.4 Serial Analysis of Gene Expression
12.6.5 Northern Blotting
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Diagnostics Centres
12.10.2 Drug Discovery
12.10.3 Research and Development
12.10.4 Others
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 DNA Microarrays
13.6.2 PCR
13.6.3 Next Generation Sequencing
13.6.4 Serial Analysis of Gene Expression
13.6.5 Northern Blotting
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Diagnostics Centres
13.10.2 Drug Discovery
13.10.3 Research and Development
13.10.4 Others
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Genetic Analyzer Market: Competitive Dashboard
14.2 Global Genetic Analyzer Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Thermo Fisher Scientific
14.3.2 BioRad Laboratories
14.3.3 Abbott laboratories
14.3.4 AutoGenomics
14.3.5 Celera Group
14.3.6 PerkinElmer
14.3.7 Quest Diagnostics
14.3.8 ELITech Group
14.3.9 Applied Biosystems
14.3.10 Transgenomic
